---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-065088"
form_type: "8-K/A"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T21:29:14.813316+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma regains Nasdaq minimum bid price compliance, delisting risk removed

## Summary
- Received Nasdaq notification on Aug 8, 2023 confirming compliance with Rule 5550(a)(2).
- Closing bid price was $1.00 or above for 10 consecutive days (July 25 – Aug 7, 2023).
- Previously received deficiency letter on Aug 19, 2022; compliance deadline extended to Aug 14, 2023.
- Matter now closed; no further action required by Nasdaq.

## SEC filing metadata
- accession: 0001213900-23-065088
- form_type: 8-K/A
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390023065088/0001213900-23-065088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390023065088/ea183183-8ka_abvcbio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-065088
- JSON: https://secwatch.observer/filing/0001213900-23-065088.json
- Plain text: https://secwatch.observer/filing/0001213900-23-065088.txt

## Key facts
- Listing & Compliance Notices
  ABVC BIOPHARMA, INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: compliance regained
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: August 8, 2023, the Company received a notification letter (the “ Notification Letter ”) from Nasdaq notifying the Company that the Staff has determined that for 10 consecutive business days, from July 25, 2023 to August 7, 2023, the closing bid price of the Company’s common stock has been at least $1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Listing Rule 5550(a)(2) and has indicated that the matter is now closed. On August 10, 2023, the Company shall issue a press release announcing that the Company received the Notification L
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390023065088/0001213900-23-065088-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.